ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 50 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $3,934,000 | +47.5% | 3,923,000 | +48.2% | 0.01% | +75.0% |
| Q2 2021 | $2,667,000 | +1069.7% | 2,647,000 | +1223.5% | 0.00% | – |
| Q4 2019 | $228,000 | +0.4% | 200,000 | 0.0% | 0.00% | – |
| Q3 2019 | $227,000 | -23.8% | 200,000 | -20.0% | 0.00% | -100.0% |
| Q2 2019 | $298,000 | -10.8% | 250,000 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $334,000 | – | 250,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TENOR CAPITAL MANAGEMENT Co., L.P. | 74,881,000 | $76,559,000 | 1.97% |
| III Capital Management | 15,000,000 | $15,227,000 | 1.82% |
| TFG Asset Management GP Ltd | 14,055,000 | $14,321,000 | 1.02% |
| MACKAY SHIELDS LLC | 28,304,000 | $28,739,000 | 0.21% |
| RWC Asset Management LLP | 6,500,000 | $6,604,000 | 0.20% |
| PALISADE CAPITAL MANAGEMENT, LP | 7,187,000 | $7,281,000 | 0.17% |
| CQS (US), LLC | 4,000,000 | $4,092,000 | 0.13% |
| FARALLON CAPITAL MANAGEMENT LLC | 24,435,000 | $24,797,000 | 0.12% |
| D. E. Shaw & Co., Inc. | 59,728,000 | $60,845,000 | 0.06% |
| BNP Paribas Asset Management Holding S.A. | 7,000,000 | $7,133,000 | 0.03% |